Overview

A Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness

Status:
COMPLETED
Trial end date:
2025-06-29
Target enrollment:
Participant gender:
Summary
To demonstrate the efficacy of BTOS-HA as non inferior to Lumify for treating ocular redness in a population of adult subjects.
Phase:
PHASE3
Details
Lead Sponsor:
Bausch & Lomb Incorporated
Treatments:
Brimonidine Tartrate